Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Review of literature on the factors affecting drug prescribing.

Hemminki E.

Soc Sci Med. 1975 Feb;9(2):111-6. Review. No abstract available.

PMID:
1093256
2.

Correlates of physicians' prescribing behavior.

Becker MH, Stolley PD, Lasagna L, McEvilla JD, Sloane LM.

Inquiry. 1972 Sep;9(3):30-42. No abstract available.

PMID:
4262972
3.

Drug product advertising and prescribing: a review of the evidence.

Smith MC.

Am J Hosp Pharm. 1977 Nov;34(11):1208-24.

PMID:
412419
4.

Direct-to-consumer prescription drug advertising: trends, impact, and implications.

Wilkes MS, Bell RA, Kravitz RL.

Health Aff (Millwood). 2000 Mar-Apr;19(2):110-28. Review.

5.

Marketing pharmaceutical products to physicians. Sales reps influence physicians' impressions of the industry.

Creyer EH, Hrsistodoulakis I.

Mark Health Serv. 1998 Summer;18(2):34-8.

PMID:
10180333
6.

Clinician attitudes towards prescribing and implications for interventions in a multi-specialty group practice.

Fortuna RJ, Ross-Degnan D, Finkelstein J, Zhang F, Campion FX, Simon SR.

J Eval Clin Pract. 2008 Dec;14(6):969-73. doi: 10.1111/j.1365-2753.2007.00913.x. Epub 2008 May 2.

PMID:
18462286
7.

Differential education concerning therapeutics and resultant physician prescribing patterns.

Becker MH, Stolley PD, Lasagna L, McEvilla JD, Sloane LM.

J Med Educ. 1972 Feb;47(2):118-27. No abstract available.

PMID:
5011761
8.

Prescribing influences: an overview.

Worthen DB.

Br J Med Educ. 1973 Jun;7(2):109-17. No abstract available.

PMID:
4725046
9.

Physicians' negative views of direct-to-consumer advertising (DTCA): the international evidence grows.

Toop L, Richards D.

N Z Med J. 2004 Jun 4;117(1195):U905. No abstract available.

PMID:
15282619
10.

The influence of pharmaceutical companies.

Parnes B.

J Fam Pract. 2000 Dec;49(12):1154-5. No abstract available.

PMID:
11132068
11.
12.

The influence of pharmaceutical companies.

Messmer JJ.

J Fam Pract. 2000 Dec;49(12):1154; author reply 1155. No abstract available.

PMID:
11132069
13.

Influencing physician prescribing.

Segal R, Wang F.

Pharm Pract Manag Q. 1999 Oct;19(3):30-50. Review.

PMID:
10747681
14.

Details, details: what your colleagues think of drug reps.

Murray D.

Med Econ. 2002 Jun 7;79(11):41-4. No abstract available.

PMID:
12096597
15.

The attitudes and beliefs of oncology nurse practitioners regarding direct-to-consumer advertising of prescription medications.

Viale PH, Sanchez Yamamoto D.

Oncol Nurs Forum. 2004 Jul 13;31(4):777-83. Print 2004 Jul.

PMID:
15252431
16.

Benefits and harms of direct to consumer advertising: a systematic review.

Gilbody S, Wilson P, Watt I.

Qual Saf Health Care. 2005 Aug;14(4):246-50. Review.

17.

Drug promotional practices in Mumbai: a qualitative study.

Roy N, Madhiwalla N, Pai SA.

Indian J Med Ethics. 2007 Apr-Jun;4(2):57-61.

PMID:
18630221
18.

Medicine and public affairs: Kennedy urges further pharmaceutical regulation.

Greenberg DS.

N Engl J Med. 1974 May 23;290(21):1211-2. No abstract available.

PMID:
4824024
19.

[What factors influence physicians' prescribing habits?].

Fugelli P.

Tidsskr Nor Laegeforen. 1977 Sep 30;97(27):1383-4. Norwegian. No abstract available.

PMID:
910237
20.

Prescribing habits of Peruvian physicians and factors influencing them.

Zárate Cárdenas E, Liosa Isenrich L.

Bull Pan Am Health Organ. 1995 Dec;29(4):328-37.

PMID:
8605524

Supplemental Content

Support Center